7ea951b6 B020 481f 8acc 12fb7a3a69fd 01
Topiramate Tablet, Film Coated
Product Images NDC 68788-7351
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68788-7351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
7ea951b6 B020 481f 8acc 12fb7a3a69fd 02
The text provides data on the cumulative rates for Time to First Seizure for two groups of patients, one treated with Topiramate 50mg/day and the other with Topiramate 400mg/day. The graph displays the results in terms of time (in days) and the proportion of patients experiencing a seizure, represented by the Y-axis. The statistical significance of the difference between the two treatments is denoted by P=0.0002.*
7ea951b6 B020 481f 8acc 12fb7a3a69fd 03
This is a chart that shows the change in the average monthly migraine period rate during a double-blind phase compared to baseline. The chart includes the results for a placebo group and three different groups receiving different doses of topiramate. The table also indicates that the results are statistically significant.*
7ea951b6 B020 481f 8acc 12fb7a3a69fd 05
Description not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
